These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12444250)

  • 1. Mutational analysis of the structural organization of polyglutamine aggregates.
    Thakur AK; Wetzel R
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17014-9. PubMed ID: 12444250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of polyglutamine aggregate cytotoxicity by a structure-based elongation inhibitor.
    Thakur AK; Yang W; Wetzel R
    FASEB J; 2004 May; 18(7):923-5. PubMed ID: 15001566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-like features of polyglutamine aggregates and their assembly kinetics.
    Chen S; Berthelier V; Hamilton JB; O'Nuallain B; Wetzel R
    Biochemistry; 2002 Jun; 41(23):7391-9. PubMed ID: 12044172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligoproline effects on polyglutamine conformation and aggregation.
    Bhattacharyya A; Thakur AK; Chellgren VM; Thiagarajan G; Williams AD; Chellgren BW; Creamer TP; Wetzel R
    J Mol Biol; 2006 Jan; 355(3):524-35. PubMed ID: 16321399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction.
    Bhattacharyya AM; Thakur AK; Wetzel R
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15400-5. PubMed ID: 16230628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins.
    Slepko N; Bhattacharyya AM; Jackson GR; Steffan JS; Marsh JL; Thompson LM; Wetzel R
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14367-72. PubMed ID: 16980414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.
    Chen S; Berthelier V; Yang W; Wetzel R
    J Mol Biol; 2001 Aug; 311(1):173-82. PubMed ID: 11469866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microtiter plate assay for polyglutamine aggregate extension.
    Berthelier V; Hamilton JB; Chen S; Wetzel R
    Anal Biochem; 2001 Aug; 295(2):227-36. PubMed ID: 11488626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unaided trifluoroacetic acid pretreatment solubilizes polyglutamine peptides and retains their biophysical properties of aggregation.
    Burra G; Thakur AK
    Anal Biochem; 2016 Feb; 494():23-30. PubMed ID: 26514067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation.
    Chen S; Ferrone FA; Wetzel R
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11884-9. PubMed ID: 12186976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations.
    Marchut AJ; Hall CK
    Proteins; 2007 Jan; 66(1):96-109. PubMed ID: 17068817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra- and intermolecular beta-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases.
    Tanaka M; Morishima I; Akagi T; Hashikawa T; Nukina N
    J Biol Chem; 2001 Nov; 276(48):45470-5. PubMed ID: 11584007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure propensities in mutated polyglutamine peptides.
    Vanschouwen BM; Oblinsky DG; Gordon HL; Rothstein SM
    Interdiscip Sci; 2011 Mar; 3(1):1-16. PubMed ID: 21369882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation kinetics of interrupted polyglutamine peptides.
    Walters RH; Murphy RM
    J Mol Biol; 2011 Sep; 412(3):505-19. PubMed ID: 21821045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor.
    Panet-Raymond V; Gottlieb B; Beitel LK; Schipper H; Timiansky M; Pinsky L; Trifiro MA
    Neurotox Res; 2001 Jul; 3(3):259-75. PubMed ID: 15111251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding of polyglutamine chains.
    Chopra M; Reddy AS; Abbott NL; de Pablo JJ
    J Chem Phys; 2008 Oct; 129(13):135102. PubMed ID: 19045125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elongation kinetics of polyglutamine peptide fibrils: a quartz crystal microbalance with dissipation study.
    Walters RH; Jacobson KH; Pedersen JA; Murphy RM
    J Mol Biol; 2012 Aug; 421(2-3):329-47. PubMed ID: 22459263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging polyglutamine deposits in brain tissue.
    Osmand AP; Berthelier V; Wetzel R
    Methods Enzymol; 2006; 412():106-22. PubMed ID: 17046655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.